Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoadjuvant Therapy × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 140 Breast 78 Thoracic 36 Genitourinary 24 Gynecologic 22 Sarcoma 19 Head & Neck 15 CNS 15 Plasma cell 6 Lymphoid 6 Tumor-Agnostic 4 Other solid neoplasm 3 Dermatologic 3 Other hematologic neoplasm 1 Endocrine 1 Classical hematology 1

Conditions

Interventions

Cyclophosphamide 80 fludarabine phosphate 72 Busulfan 52 Cyclosporine 51 Whole-Body Irradiation 47 Epoetin Alfa 46 Mycophenolic Acid 45 Peripheral Blood Stem Cell Transplantation 43 fludarabine 36 Cytarabine 35 Filgrastim 34 Antilymphocyte Serum 34 Melphalan 33 Darbepoetin alfa 33 Tacrolimus 31 Methotrexate 27 Radiotherapy 25 Cord Blood Stem Cell Transplantation 25 Granulocyte Colony-Stimulating Factor 20 Methylprednisolone 18 Etoposide 18 eltrombopag 15 apixaban 14 Azacitidine 14 Alemtuzumab 14 ferric carboxymaltose 13 Dalteparin 13 Thiotepa 12 thymoglobulin 11 epoetin beta 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00875004 2024-06-26

PLATON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡